Researchers at the University of Liverpool have developed a mathematical model that has the potential to improve the performance of endovascular aneurysm sealing (EVAS), which is an innovative procedure to treat abdominal aortic aneurysms (AAA). AAA is a swelling of part of the aorta inside the abdomen caused by a weakness in the aortic wall … Continue reading New model to study endovascular aneuryism sealing

South Asian people with rheumatoid arthritis (RA) now have extra help in living with their condition thanks to a new educational video that encourages them to understand when and why they need to move from standard treatment to treatment with a biologic. The University of Birmingham reports the short educational video is produced by the … Continue reading New video for South Asian people with rheumatoid arthritis

Researchers from the University of Liverpool’s Institute of Translational Medicine and Alder Hey Children’s NHS Foundation Trust will join a UK-wide effort, including colleagues from five other universities, to drive the development of new, targeted treatments for children and young people with juvenile idiopathic arthritis (JIA) and its associated eye inflammation condition, uveitis. The University … Continue reading Transforming treatment for arthritis and uveitis

The first NHS-led clinical trial for thyroid eye disease (TED), a disfiguring condition causing protruding eyes, double vision and swelling around the eyes, has shown that widely used, expensive and time consuming radiotherapy treatment does not help people who are also given steroid tablets. However, disease severity was reduced in people who also received antiproliferative … Continue reading First NHS-led clinical trial for thyroid eye disease

The University of Liverpool is leading on a major new collaborative project to develop a Zika virus vaccine that is suitable for use in pregnancy. The University of Liverpool reports the project, supported by a £4.7m award from Department of Health and Social Care, and managed by Innovate UK, aims to take two new vaccine … Continue reading University of Liverpool leading £4.7m Zika vaccine project

A recently formed Manchester health consortium, led by the Christie NHS Foundation Trust, has been awarded £6.8m in funding to ensure more people benefit from a new generation of disease fighting drugs for cancer and non-cancer illnesses. The University of Manchester reports Manchester is one of only three centres in the UK awarded funding by … Continue reading £6.8m award to Manchester health consortium

A recently formed health consortium, jointly led by the Welsh Blood Service (on behalf of NHS Wales) and the National Institute for Health Research Birmingham Biomedical Research Centre, has been awarded £7.3m of UK Government funding to ensure more people benefit from a new generation of breakthrough therapies. Abertawe Bro Morgannwg University Health Board reports … Continue reading £7.3m award brings advanced medical therapies to Wales

University of Liverpool scientists have been awarded £1.5m by Cancer Research UK to help boost understanding about pancreatic cancer, one of the deadliest cancers. The University of Liverpool reports its Institute of Translational Medicine is leading the study and will analyse tissue and blood samples from people with pancreatic cancer treated at Royal Liverpool Hospital … Continue reading £1.5m award to improve pancreatic cancer treatments

A study jointly led by the University of Birmingham and University of Edinburgh has revealed that a new scanning technology could almost halve the number of liver biopsies carried out on people with fatty liver disease. The University of Birmingham reports the authors of the study, which was also carried out in collaboration with the … Continue reading Scanning technology could halve number of liver biopsies

The University of Birmingham will play a leading role in a new £2.3m clinical trial aimed at improving treatment to prevent potentially deadly bleeding in people with liver cirrhosis. The University of Birmingham understands the CALIBRE (Carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis) trial is to be the … Continue reading £2.3m clinical trial to improve treatment of liver cirrhosis